Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,258 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,258 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,258 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,258 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,258 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,258 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,258 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
28 Jan 2026
Bought on a plan 2×
$20.89M 308,931 at 67.61
0.6%
Bought on a plan
28 Jan 2026
Eric P Lefkofsky CEO and Chairman · indirect
Sold on a plan 4×
$10.90M 166,250 at 65.56
1.8%
Planned (10b5-1)
28 Jan 2026
Steve Sanghi President, CEO and Chair of Bd · indirect
Sold on a plan
$7.96M 98,814 at 80.55
1.0%
Planned (10b5-1)
28 Jan 2026
James John Walker Chief Executive Officer
Sold on a plan 6×
$6.64M 195,000 at 34.04
43.8%
Planned (10b5-1)
28 Jan 2026
Michael N Intrator CEO and President · indirect
Sold on a plan 11×
$5.30M 50,000 at 106.08
100%
Sold half or more
28 Jan 2026
Alexis Le-Quoc Chief Technology Officer
Sold on a plan 4×
$4.57M 32,418 at 140.99
9.7%
Planned (10b5-1)
28 Jan 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$3.73M 632,874 at 5.89
22.7%
Planned (10b5-1)
28 Jan 2026
Michael N Intrator CEO and President
Sold on a plan 11×
$3.44M 32,456 at 106.08
0.6%
Planned (10b5-1)
28 Jan 2026
Jaisun Garcha Chief Financial Officer
Sold on a plan 3×
$2.55M 75,000 at 34.04
23.1%
Planned (10b5-1)
28 Jan 2026
Richard T Hume Director
Sold on a plan 2×
$2.08M 12,991 at 160.34
21.5%
Planned (10b5-1)
28 Jan 2026
Karen J Holcom SVP & Chief Financial Officer
Sold on a plan
$1.54M 4,974 at 309.23
18.8%
Planned (10b5-1)
28 Jan 2026
Sold on a plan 2×
$1.43M 49,882 at 28.57
100%
Sold half or more
28 Jan 2026
Sold on a plan
$1.41M 86,639 at 16.29
0.8%
Planned (10b5-1)
28 Jan 2026
Daniel Patrick O'Day Chairman & CEO
Sold on a plan 2×
$1.40M 10,000 at 139.89
1.8%
Planned (10b5-1)
28 Jan 2026
Eimear P Bonner Chief Financial Officer
Sold on a plan
$1.28M 7,534 at 170.00
63.3%
Sold half or more
28 Jan 2026
Peuch Olivier Le Chief Executive Officer
Sold on a plan
$1.26M 25,000 at 50.40
1.7%
Planned (10b5-1)
28 Jan 2026
Scott Farquhar Director · indirect
Sold on a plan 5×
$1.04M 7,665 at 135.44
2.3%
Planned (10b5-1)
28 Jan 2026
Michael Cannon-Brookes CEO, Co-Founder · indirect
Sold on a plan 5×
$1.04M 7,665 at 135.44
2.3%
Planned (10b5-1)
28 Jan 2026
Louise Frederika Kooij Chief Accounting Officer
Sold on a plan
$1.04M 32,612 at 31.80
57.2%
Sold half or more
28 Jan 2026
Steven Leonard Chapman CEO and President
Sold on a plan
$866.99K 3,648 at 237.66
1.7%
Planned (10b5-1)
28 Jan 2026
Jeremy Stoppelman Chief Executive Officer
Sold on a plan
$831.75K 30,000 at 27.73
3.8%
Planned (10b5-1)
28 Jan 2026
Scot B Jarvis Director
Sold on a plan 2×
$591.38K 5,000 at 118.28
4.7%
Planned (10b5-1)
28 Jan 2026
Michael Burkes Brophy Chief Financial Officer
Sold on a plan 2×
$573.22K 2,413 at 237.56
3.8%
Planned (10b5-1)
28 Jan 2026
Alana K Knowles Controller
Sold on a plan
$544.00K 3,200 at 170.00
72.6%
Sold half or more
28 Jan 2026
David C Kuo *** See Remarks
Sold on a plan
$540.66K 12,000 at 45.06
9.5%
Planned (10b5-1)
28 Jan 2026
Maria G Freve See Remarks
Sold on a plan 4×
$457.72K 8,306 at 55.11
93.9%
Sold half or more
28 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$285.19K 1,200 at 237.66
0.8%
Planned (10b5-1)
28 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$237.66K 1,000 at 237.66
0.4%
Planned (10b5-1)
28 Jan 2026
Richard A Hayne CEO & Chairman of the Board
Sold on a plan
$231.44K 3,304 at 70.05
0.0%
Planned (10b5-1)
28 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$220.55K 928 at 237.66
0.5%
Planned (10b5-1)
28 Jan 2026
Richard A Hayne CEO & Chairman of the Board · indirect also filed by Margaret Hayne
Sold on a plan
$202.44K 2,890 at 70.05
0.1%
Planned (10b5-1)
28 Jan 2026
Camellia E FitzGerald Chief Accounting Officer
Sold on a plan
$134.88K 2,810 at 48.00
22.0%
Planned (10b5-1)
28 Jan 2026
William Yeung Chief Legal Officer
Sold on a plan
$105.79K 7,271 at 14.55
7.5%
Planned (10b5-1)
28 Jan 2026
Eric Richard Remer Chief Executive Officer
Sold on a plan
$98.78K 8,268 at 11.95
0.3%
Planned (10b5-1)
28 Jan 2026
Steven Yi See Remarks
Sold on a plan
$84.59K 8,000 at 10.57
0.3%
Planned (10b5-1)
28 Jan 2026
Eugene Nonko Director · indirect
Sold on a plan
$70.81K 6,700 at 10.57
0.4%
Planned (10b5-1)
28 Jan 2026
Eugene Nonko Director
Sold on a plan
$57.15K 5,400 at 10.58
0.6%
Planned (10b5-1)
28 Jan 2026
Tim Watkins CMO & Head of Development
Sold on a plan 2×
$51.19K 3,611 at 14.18
100%
Sold half or more
28 Jan 2026
Jonathan Sheena Director
Sold on a plan
$45.39K 191 at 237.66
0.1%
Planned (10b5-1)
28 Jan 2026
Ned S Holmes Director · indirect
Sold on a plan 4×
$40.00K 600 at 66.67
1.4%
Planned (10b5-1)
28 Jan 2026
Ned S Holmes Director
Sold on a plan 3×
$33.35K 500 at 66.69
0.6%
Planned (10b5-1)
28 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$23.19K 6,500 at 3.57
100%
Sold half or more
28 Jan 2026
Sold on a plan
$20.50K 25,000 at 0.82
20.0%
Planned (10b5-1)
28 Jan 2026
John R Gallagher Chief Operating Officer
Sold on a plan
$13.62K 430 at 31.67
1.3%
Planned (10b5-1)
28 Jan 2026
Derek M Meisner Chief Legal Officer & Corp Sec
Sold on a plan
$8.02K 2,671 at 3.00
1.5%
Planned (10b5-1)
28 Jan 2026
Sold on a plan
$3.40K 100 at 34.00
0.7%
Planned (10b5-1)
28 Jan 2026
Ilan Ganot Director · indirect
Sold on a plan
$1.26K 191 at 6.59
1.1%
Planned (10b5-1)
Showing 17,951–18,000 of 23,258. ← Newer Page 360 of 466 Older →